Gilead’s experimental drug for patients with severe Covid-19 infections showed promise in an early analysis https://t.co/oaU6VWPnnr
— Bloomberg (@business) April 11, 2020
Gilead’s experimental drug for patients with severe Covid-19 infections showed promise in an early analysis https://t.co/oaU6VWPnnr
— Bloomberg (@business) April 11, 2020